28 Capital - Crunchbase Company Profile & Funding

Overview

28 Capital

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About 28 Capital

CB Rank

584900

28 Capital is a venture capital firm that provides funding and support services for life sciences startups.

Private

Boston, Massachusetts, United States

1-10

28cap.com

Angel Investment

Life Science

Venture Capital

Key People

Audrey Warner: Managing Partner & Co-Founder
John Boyce: Managing Partner & Co-Founder
Past Role: Exosome Diagnostics, President & CEO

Details

Legal Name

28 Capital LLC.

Operating Status

Active

Company Type

For Profit

Founders

Audrey Warner, John Boyce

Predictions & Insights

Growth Prediction

See this Growth Prediction

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Investments

Investment Breakdown

Number of Investments

See investment data for this company, with details on deal size, industry, stage, and more.

Announced Date	Organization Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Precede Biosciences	—	Series B - Precede Biosciences	obfuscated obfuscation
obfuscated obfuscation	Precede Biosciences	—	Series B - Precede Biosciences	obfuscated obfuscation
obfuscated obfuscation	Precede Biosciences	—	Series B - Precede Biosciences	obfuscated obfuscation
obfuscated obfuscation	Precede Biosciences	—	Series B - Precede Biosciences	obfuscated obfuscation
obfuscated obfuscation	Precede Biosciences	—	Series B - Precede Biosciences	obfuscated obfuscation

Investment Breakdown

Number of Investments

See investment data for this company, with details on deal size, industry, stage, and more.

Announced Date	Organization Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Precede Biosciences	—	Series B - Precede Biosciences	obfuscated obfuscation
obfuscated obfuscation	Precede Biosciences	—	Series B - Precede Biosciences	obfuscated obfuscation
obfuscated obfuscation	Precede Biosciences	—	Series B - Precede Biosciences	obfuscated obfuscation
obfuscated obfuscation	Precede Biosciences	—	Series B - Precede Biosciences	obfuscated obfuscation
obfuscated obfuscation	Precede Biosciences	—	Series B - Precede Biosciences	obfuscated obfuscation